Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The INK4 and CIP cyclin-dependent kinase (Cdk) inhibitors (CKI) activate pocket protein function by suppressing Cdk4 and Cdk2, respectively. Although these inhibitors are lost in tumors, deletion of individual CKIs results in modest proliferation defects in murine models. We have evaluated cooperativity between loss of all INK4 family members (using cdk4r24c mutant alleles that confer resistant to INK4 inhibitors) and p21(Waf1/Cip1) in senescence and transformation of mouse embryo fibroblasts (MEF). We show that mutant cdk4r24c and p21 loss cooperate in
pRb
inactivation and MEF immortalization. Our studies suggest that cdk4r24c mediates resistance to p15(INK4B)/p16(INK4A) that accumulates over passage, whereas loss of p21 suppresses
hyperoxia
-induced Cdk2 inhibition and
pRb
dephosphorylation on MEF explantation in culture. Although cdk4r24c and p21 loss cooperate in H-ras(V12)/c-myc-induced foci formation, they are insufficient for oncogene-induced anchorage-independent growth. Interestingly, p21(-/-); cdk4r24c MEFs expressing H-ras(V12) and c-myc display detachment-induced apoptosis and are transformed by c-myc, H-ras(V12), and Bcl-2. We conclude that the INK4 family and p21 loss cooperate in promoting
pRb
inactivation, cell immortalization, and H-ras(V12)/c-myc-induced loss of contact inhibition. In addition, absence of
pRb
function renders H-ras(V12) + c-myc-transduced fibroblasts prone to apoptosis when deprived of the extracellular matrix, and oncogene-induced anchorage-independent growth of pocket protein-deficient cells requires apoptotic suppression.
...
PMID:p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts. 1748 23
Senescence is a potential tumor-suppressing mechanism and a commonly used model of cellular aging. One current hypothesis to explain senescence, based in part on the correlation of oxygen with senescence, postulates that it is caused by oxidative damage from reactive oxygen species (ROS). Here, we further test this theory by determining the mechanisms of
hyperoxia
-induced senescence. Exposure to 70% O(2) led to stress-induced, telomere-independent senescence. Although
hyperoxia
elevated mitochondrial ROS production, overexpression of antioxidant proteins was not sufficient to prevent
hyperoxia
-induced senescence.
Hyperoxia
activated AMPK; however, overexpression of a kinase-dead mutant of LKB1, which prevented AMPK activation, did not prevent
hyperoxia
-induced senescence. Knocking down p21 via shRNA, or suppression of the p16/
pRb
pathway by either BMI1 or HPV16-E7 overexpression, was also insufficient to prevent
hyperoxia
-induced senescence. However, suppressing p53 function resulted in partial rescue from senescence, suggesting that
hyperoxia
-induced senescence involves p53. Suppressing both the p53 and
pRb
pathways resulted in almost complete protection, indicating that both pathways cooperate in
hyperoxia
-induced senescence. Collectively, these results indicate a ROS-independent but p53/
pRb
-dependent senescence mechanism during
hyperoxia
.
...
PMID:Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS. 1894 82